EcoDrugPlus

Tubulin Alpha 1a

Ensembl ID : ENSPVAG00000004645
Gene Symbol: TUBA1A
1 Cross references
121 Possible Orthologues:

Tubulin Alpha 4a

Ensembl ID : ENSPVAG00000010798
Gene Symbol: TUBA4A
1 Cross references
224 Possible Orthologues:

Tubulin Beta 1 Class Vi

Ensembl ID : ENSPVAG00000000207
Gene Symbol: TUBB1
1 Cross references
186 Possible Orthologues:

Tubulin Beta 2a Class Iia

Ensembl ID : ENSPVAG00000003354
Gene Symbol: TUBB2A
1 Cross references
161 Possible Orthologues:

Tubulin Beta 2b Class Iib

Ensembl ID : ENSPVAG00000013676
Gene Symbol: TUBB2B
1 Cross references
141 Possible Orthologues:

Tubulin Beta 3 Class Iii

Ensembl ID : ENSPVAG00000003011
Gene Symbol: TUBB3
1 Cross references
144 Possible Orthologues:

Tubulin Beta 4a Class Iva

Ensembl ID : ENSPVAG00000007258
Gene Symbol: TUBB4A
1 Cross references
94 Possible Orthologues:

Tubulin Beta 4b Class Ivb

Ensembl ID : ENSPVAG00000008384
Gene Symbol: TUBB4B
1 Cross references
316 Possible Orthologues:

Tubulin Beta 6 Class V

Ensembl ID : ENSPVAG00000001860
Gene Symbol: TUBB6
1 Cross references
141 Possible Orthologues:

Tubulin Beta Class I

Ensembl ID : ENSPVAG00000003989
Gene Symbol: TUBB
1 Cross references
291 Possible Orthologues:

Tumor Protein P53

Ensembl ID : ENSPVAG00000016317
Gene Symbol: TP53
1 Cross references
253 Possible Orthologues:

Tyrosinase

Ensembl ID : ENSPVAG00000004529
Gene Symbol: TYR
1 Cross references
266 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).